BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
 News By Date

SuMoTuWeThFrSa
31123456
78910111213
14151617181920
21222324252627
2829301234
567891011

 Tuesday, September 16, 2014
 Top Breaking News
New York-Based SIGA Technologies, Inc. (SIGA) Files For Bankruptcy
Eli Lilly and Company (LLY) Bets $500 Million On AstraZeneca PLC (AZN)’s Alzheimer's Drug
Takeda Pharmaceutical Co. Ltd. (TKPYY) To Headquarter Global Oncology Unit In Crowded Cambridge
UC Launches $250M Venture Fund To Back Homegrown Startups
Merck & Co. (MRK)'s Long-Delayed Osteoporosis Drug Passes Trial
Regeneron Pharmaceuticals, Inc. (REGN) Wins Breakthrough Therapy Designation From FDA For EYLEA
Novartis AG (NVS), Roche (RHHBY) Cry Foul On New Swiss Pricing System
Lupin Ltd. (LUPN.BO), Merck Serono Forge Emerging Markets Pact; Deal Could Add Up To 20 Drugs To Merck's Portfolio
Israeli Biotech NeuroDerm Ltd. Files For $65 Million IPO
Human Hair Discovered In Heparin Vial Prompts Hospira, Inc. Recalls
Fall Parade Of Biotech IPOs Sees Heavy Lineup
Wall Street Shouldn't Write Off Ampio Pharmaceuticals, Inc. (AMPE) Yet: Citi Analysts
Experimental Northwest Biotherapeutics (NWBO) Drug Gets First Slot Under UK Early Access Scheme
GlaxoSmithKline (GSK) Exercises Option For Five Prime Therapeutics, Inc. (FPRX)'s Skeletal Muscle Drugs
Analyst: Safety Worries Dog Merck & Co. (MRK)’s Osteoporosis Drug
FDA Approves AstraZeneca PLC (AZN)'s MOVANTIK™ For Opioid-Induced Constipation
Study Shows Novo Nordisk A/S (NVO)'s New Diabetes Drug Tresiba Effective And Safe For Children
Dimension Therapeutics Appoints New CEO, Dr. Annalisa Jenkins
 Featured Stories
 More News
EPIRUS’ Remicade® Biosimilar Receives Final Approvals In India
Salix Pharmaceuticals, Ltd. (SLXP) Release: UCERIS® (budesonide) 2mg Rectal Foam For The Induction Of Remission Of Mild-To-Moderate Distal Ulcerative Colitis Granted Tentative Approval By FDA
Boehringer Ingelheim Corporation Release: Type 2 Diabetes: Investigational Empagliflozin/Linagliptin Combination Tablet Shows Sustained Reduction In Blood Glucose In Phase 3 Study
Amgen (AMGN) Announces Results From Several New Exploratory Analyses Evaluating Long-Term Impact Of Treatment With Prolia® (Denosumab) In Postmenopausal Women With Osteoporosis
Bayer HealthCare Pharmaceuticals (BAYA.F) And Orion Corporation Initiate Phase 3 Trial Of ODM-201 In Men With High-Risk Non-Metastatic Castration-Resistant Prostate Cancer
OncoGenex Pharmaceuticals Inc. (OGXI) Announces Completion Of Patient Enrollment In The Phase 3 AFFINITY Trial Of Custirsen In Combination With Cabazitaxel/Prednisone As Second-Line Chemotherapy In Men With Metastatic Castrate-Resistant Prostate Cancer
CSL Behring Announces Last Patient Treated In Phase 3 Study Of Fibrinogen Concentrate To Control Bleeding During Aortic Aneurysm Surgery
Agile Therapeutics, Inc. Initiates Phase 3 SECURE Study For Twirla™
ZS Pharma (ZSPH) Presents New Data From ZS003 A Two Week Phase 3 Trial Demonstrating That ZS-9 Prevented Recurrence Of Hyperkalemia In Heart Failure Patients On RAASi
Relypsa, Inc. (RLYP) Announces New Analysis Of Phase 3 Data Demonstrating Patiromer's Ability To Rapidly Correct, And Prevent Recurrence Of, Hyperkalemia In Heart Failure And Non-Heart Failure Patients
Mylan Inc. (MYL) Commences Phase 3 Clinical Trials For Its Generic Version Of Advair Diskus® And Insulin Analog To Lantus®
Anergis Reports Positive Long-Term Clinical Efficacy Of Lead Compound AllerT
NovaBiotics Ltd Receives Orphan Drug Status From FDA For Lynovex® For The Treatment Of Cystic Fibrosis
Ascendis Pharma A/S Announces Positive Interim Results From A Phase 2 Pediatric Study Of Once-Weekly Transcon Growth Hormone For The Treatment Of Growth Hormone Deficiency
Ophthotech Corporation (OPHT) Announces Fovista® Phase 2b Independent Analysis Shows That Fovista® Anti-PDGF Therapy, Combined With Anti-VEGF Therapy, Is Associated With A Reduction Of Sub-Retinal Fibrosis In Wet AMD Patients
Thrasos Therapeutics Announces Successful Formal Interim Analysis And Clinical Update For Phase 2 Study Of THR-184 For Acute Kidney Injury
TapImmune Inc. (TPIV) Releases Positive Interim Data On Phase I Clinical Trial Of Folate Receptor Alpha Antigens In Ovarian And Breast Cancer
Virology Publishes Genocea Biosciences HSV-2 Antigen Discovery Paper
Cleveland Biolabs Inc. (CBLI) Announces Approval To Start Phase 1 Study For Hematopoietic Stem Cell Mobilizer CBLB612 In Russian Federation
DNAtrix, Inc. Announces Treatment Of First Patient With DNX-2401 In Recurrent Glioblastoma Trial
Vince & Associates Clinical Research Completes Enrollment Of Human Abuse Liability Study For Centanafadine For Adult ADHD
Antisense Therapeutics Limited (ANP.AX) Release: ATL1102 For MS Further Development Plans – U.S. FDA Pre-IND Response Timing Confirmed; European Patent Allowance
Alnylam Pharmaceuticals (ALNY) Presents New Pre-Clinical Data With ALN-CC5, A Subcutaneously Administered Rnai Therapeutic Targeting Complement Component C5 In Development For The Treatment Of Complement-Mediated Diseases
Vaxxas Inc. Initiates Research Project On Advancing Next Generation Technology For Polio Vaccine Delivery
Data Published Online In The Journal Of Clinical Psychiatry Show Long-Term Benefit Of Non-Drug NeuroStar TMS Therapy® In Patients With Treatment Resistant Depression
Galen Signs Exclusive Deal in Europe
Relmada Therapeutics Enters Into Agreement With Memorial Sloan-Kettering Cancer Center To Better Clarify Unique Mechanism Of Action For LevoCap ER
Curie-Cancer And Inventiva Announce A Partnership In Epigenetics For The Treatment Of Cancer
PHARNEXT And The Hereditary Neuropathy Foundation Collaborate To Increase Awareness Of Charcot-Marie-Tooth Disease
Cannabis Science Inc. And Unistraw Holdings Join Forces To Produce Proprietary Formulations Delivering A Wide Array Of Unique Cannabis Extracts And Pure Cannabinoid-Based Products
WellDoc And American Diabetes Association's Maryland Chapter Announce A New Collaboration To Empower People With Type 2 Diabetes To Manage Their Condition
Axxess Pharma, Inc. Expands Global License Agreement With ABG TapouT To Include Several New High Demand Products
JDRF And Tidepool Partner To Bring Data To An Open Source Platform For People With Type 1 Diabetes
Coldstream Laboratories Inc. Partners With CytImmune Sciences Inc. For Phase 2 Sterile Manufacturing
Aphios Awarded Grant For Developing Cgmp Process For CBD Using Green Drug Manufacturing Technology
Oculus Innovative Sciences, Inc. (OCLS) Strengthens Intellectual Property Portfolio With Allowance Of Four New Patents For Microcyn® Technology
Advanced Medical Isotopes Corporation Licensed Brachytherapy Seed Patent Granted
Spectrum Pharmaceuticals, Inc. (SPPI) Announces Issue Of A New Patent For Beleodaq™ (Belinostat) For Injection With Patent Term Adjustment Till 2027
Trevena, Inc. (TRVN) Granted Key U.S. Composition Of Matter Patent For TRV130
Parion Sciences Announces $3 Million Award From Cystic Fibrosis Foundation Therapeutics, Inc. To Accelerate The Development Of Novel CF Treatment
Jeffrey Modell Foundation Awards $1 Million For Translational Research
New York Blood Center Receives $2 Million In NIDA Funding To Develop HIV Self-Testing Intervention
Valeant Pharmaceuticals International (VRX) Announces Redemption Of All Of The Outstanding $500.0 Million Aggregate Principal Amount Of Its 6.75% Senior Notes Due 2017
Pivotal Therapeutics Inc. Grants Incentive Stock Options
Opexa Therapeutics (OPXA) Announces Termination of Public Offering of Common Stock
CorMedix (CRMD) Amends And Restates Outstanding Securities To Remove Provisions Causing Derivative Liability Classification
CryoPort, Inc. Engages Broekman Group To Enhance Its Logistics And Operational Support In Europe
Nolato: New Braille Printing Developed For Plastic Pharmaceutical Packaging
Syneron Inc. Announces Details For Upcoming Investor Meeting
Nordic Nanovector: Final Result Of The Subsequent Offering
Allergan Inc. (AGN) To Hold Special Meeting Of Stockholders On Originally Scheduled Date Of December 18 Without Restriction
e-Therapeutics plc Release: Four Clinical Trials In Progress; New Drug Candidates In Laboratory Testing
Opexa Therapeutics (OPXA) Announces Proposed Public Offering Of Common Stock
Celator Pharmaceuticals, Inc. To Ring The NASDAQ Stock Market Closing Bell
Oxygen Biotherapeutics, Inc. Announces Name Change To Tenax Therapeutics
Pluristem Therapeutics (PSTI) Pursues Development Strategy In Japan Where New Law Accelerates Path To Market
Syngene Release: Respected Synthetic Biology Group Chooses G:BOX Chemi XT4
Fujifilm Diosynth Biotechnologies Chooses ambr250 System For Optimising Microbial Fermentation
CluePoints Statistical Monitoring Used To Check Data Quality In Large Phase III Gastric Cancer Trial
Pershing Square, Valeant Pharmaceuticals International (VRX) And Allergan Inc. (AGN) Settle Pending Litigation Before The Delaware Court Of Chancery
Bioheart, Inc. Announces Grand Opening Of Facility In South Africa
NMS Labs Announces Crucial New Tool For Impaired Driving Investigation
Top 5 Pharma Company Receives FDA Validation Using Transend By PDS
Biota Pharmaceuticals, Inc. (BOTA) To Host Conference Call To Report Fourth Quarter And Year-End 2014 Financial Results On September 26, 2014
Newron Pharmaceuticals (NWRN) Reports Half-Year Results 2014
Parnell Pharmaceuticals Holdings Announces Fiscal Year 2014 Financial Results
OncoSec Medical Inc. Appoints Dr. Mai H. Le To Position Of Chief Medical Officer And Names Dr. Robert H. Pierce As Chief Scientific Officer
Innate Pharma (IPH.PA ) Appoints Pierre Dodion As Chief Medical Officer And Member Of The Executive Committee
AMAG Pharmaceuticals, Inc. (AMAG) Appoints Judith Johnson, M.D. As Vice President Of Pharmacovigilance And Pharmacoepidemiology
FORMA Therapeutics, Inc. Appoints Mary Wadlinger, Senior Vice President, Human Resources, To Executive Leadership Team
Dicerna Pharmaceuticals (DRNA) Announces Appointment Of Biotech Industry Leader Bruce Peacock To Its Board Of Directors And Audit Committee
Dr. Mark Roskey Joins Quanterix Leadership Team
SAGE Therapeutics Appoints Michael F. Cola To The Company's Board Of Directors
Thermo Fisher Scientific (TMO) Appoints New Members To Scientific Advisory Board
SeraCare Life Sciences, Inc. (SRLS) Unveils Nets For Kids Program
Abbott Laboratories (ABT) Included In Top 10 Best Companies By Working Mother Magazine
Synthetic Biologics, Inc. (SYN)' Statin-Class Candidate For Constipation-Predominant Irritable Bowel Syndrome Detailed At Company's Investor Day
American Heart Association Recognizes "Heart Of Chicago" Companies, Sponsors Who Support The Association At The Highest Level In Metro Chicago
Working Mother Names Eli Lilly and Company (LLY) To Its 100 Best Companies List For 20 Years
13-Year-Old Boy With Failed Fontan Circulation Bridged To Transplant Using The SynCardia Systems, Inc. Total Artificial Heart, Published In Annals Of Thoracic Surgery
Association For The Advancement Of Wound Care Acknowledges 2014 Corporate Sponsors And Announces Open Enrollment For The 2015 Sponsorship Program
Health Canada Release: Canada Offers Essential Protective Equipment To Help Stop The Spread Of Ebola In West Africa
Acceleron Pharma To Host Educational Webcast Series With Clinical Thought Leaders
ICON’s Cynthia Dukes Voted One Of The World’s Most Influential People In Vaccines
Ce3 Release: SQA Poster Award
Zoetis (ZTS) Ranked Among Top Ten Companies For Working Mothers
Halloran Consulting Group Moves To Boston’s Innovation District, Announces Inc. Magazine Recognition As One Of America’s Fastest-Growing Companies
Cancer Treatment Centers Of America Receives Angel Award For Outstanding Medical Service From Imerman Angels
DrugDev CEO Ibraheem Mahmood Shortlisted For 2014 SCRIP Awards
Syneron Medical Ltd. (ELOS)'s elure™ Wins Allure Magazine's BEST OF BEAUTY Award For The Fourth Consecutive Year
EnGeneIC Pty Ltd Named A Recipient Of The Cancer Institute NSW Premier's Award For Excellence In Translational Cancer Research
New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density
Heptares To Present On Structure-Based Drug Design Using G Protein-Coupled Receptors At Inaugural Chemistry & Engineering News Virtual Symposium
Henry Schein, Inc. (HSIC) To Present At The Leerink Partners Services Roundtable
Imprimis Pharmaceuticals (immy) To Present At Craig-Hallum Alpha Select Conference
Ocular Therapeutix, Inc. (OCUL) To Present At The 21st Annual NewsMakers In The Biotech Industry Investment Conference On Friday, September 26
New Data Supporting VBI's Prophylactic Cytomegalovirus (CMV) Vaccine Candidate (VBI-1501A) Presented At The 54th ICAAC Conference In Washington, D.C.
LabCorp/ARCA biopharma GENETIC-AF Poster Presented At The 18th Annual Scientific Meeting Of The Heart Failure Society Of America
Osiris Therapeutics, Inc. (OSIR) Release: Grafix® Featured In Plenary Session Oral Presentation At The Joint Annual Meeting Of The Eastern And New England Vascular Societies
LifeScience Alley® 30th Anniversary Conference To Feature Global Healthcare Leaders
electroCore To Present At Major European Headache Meeting (EHMTIC) On The Success Of Its Non-Invasive Vagus Nerve Stimulation Therapy For Cluster Headache
Rexahn Pharmaceuticals, Inc. (RNN) To Present At The BioPharm America™ 2014 In Boston, Massachusetts, USA
Targeted Medical Pharma To Present At Sachs Associated 14th Annual Biotech In Europe Forum For Global Partnering And Investment
AxoGen, Inc. (AXGN) To Host Surgeon Education Event At American Society For Surgery Of The Hand 2014 Annual Meeting
Kite Pharma, Inc. (KITE) To Present At The 21st Annual Newsmakers In The Biotech Industry Investment Conference On Friday, September 26
Aastrom Biosciences, Inc. (ASTM) To Present Three-Year Data From The SUMMIT Extension Study Of MACI™ At The 2015 American Academy Of Orthopedic Surgeons Annual Meeting
RedHill Biopharma Ltd. (RDHL) To Present At The 14th Annual Biotech In Europe Forum For Global Partnering & Investment
NovaBay Pharmaceuticals, Inc. (NBY) Will Feature i-Lid Cleanser For The First Time At Vision Expo West
Cardioxyl Pharmaceuticals Presents Oral Heart Failure Treatment Data For Its Experimental HNO Prodrug At HFSA 18th Annual Scientific Meeting
Ignyta (RXDX) Announces RXDX-101 Phase I Data Presentation At The 2014 ESMO Congress
IMRIS CEO Jay D. Miller To Present At The 5th Annual Craig-Hallum Alpha Select Conference